Fenebrutinib HCl
Fenebrutinib (GDC-0853) is an orally bioavailable, potent, and selective small molecule inhibitor of Bruton's tyrosine kinase (BTK) . It blocks BCR signaling, inhibiting the proliferation and survival of malignant B-cells in hematological cancers, as demonstrated in both in vitro and in vivo preclinical studies.
Product Specifications
CAS Number
2128304-54-9
Smiles
Cl.C[C@H]1CN (CCN1c1ccc (Nc2cc (cn (C) c2=O) -c2ccnc (N3CCn4c5CC (C) (C) Cc5cc4C3=O) c2CO) nc1) C1COC1
Molecular Formula
C37H45ClN8O4
Molecular Weight
701.27
Storage Conditions
-20°C
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
